Delivery Order SPE2DR25D3016-SPE2DR26FG3BR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,843.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on December 15, 2025, with an ultimate completion date of December 16, 2025. This competitively awarded, firm fixed-price delivery order was not set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count) with a contract ceiling value of $9,131.84. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,774.90 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction for pharmaceutical supplies to support...
- The Defense Logistics Agency awarded a delivery order valued at $2,528.49 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. The contract is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $34,947.77 delivery order to AmerisourceBergen Drug Corp (via parent company Cencora, Inc.) on January 6, 2026, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30. The contract is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a fully competitive, non-set-aside basis, demonstrating the contractor's...
- The Defense Logistics Agency awarded a $4,677.35 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 11, 2025, with a completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $5,011.68 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a completion deadline of December 5, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,553.06 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) with an ultimate completion date of December 9, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive award criteria. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,595.64 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on December 4, 2025, with completion scheduled for December 5, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract represents a single pharmaceutical procurement supporting federal medical supply needs, leveraging AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,030.16 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30 count) on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG3BRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,529.94 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 milligram tablets (30-count units). This non-competitive delivery order, issued on January 8, 2026, with an ultimate completion date of January 9, 2026, represents a firm fixed-price transaction for pharmaceutical supply to federal medical procurement needs. The contractor is based in Conshohocken, Pennsylvania, and serves as a critical vendor for military and veteran healthcare systems across the federal government. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs globally. The contract vehicle enables efficient fulfillment of essential pharmaceutical needs by military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 1/7/26 |